Gene delivery is a transport of genes of therapeutic values into the chromosomes of the cells or tissues which can be targeted to replace the faulty genes. In last two decades lot of research efforts are dedicated to gene delivery for therapeutic applications. Today gene therapy is promising approach in treatment of genetic diseases including mitochondrial related diseases like blindness, muscular dystrophy, cystic fibrosis, and some cancers. Gene Delivery Systems: Nano Delivery Technologies observes the exploration of nanotechnology for gene therapy and gene delivery. Written by prominent…mehr
Gene delivery is a transport of genes of therapeutic values into the chromosomes of the cells or tissues which can be targeted to replace the faulty genes. In last two decades lot of research efforts are dedicated to gene delivery for therapeutic applications. Today gene therapy is promising approach in treatment of genetic diseases including mitochondrial related diseases like blindness, muscular dystrophy, cystic fibrosis, and some cancers. Gene Delivery Systems: Nano Delivery Technologies observes the exploration of nanotechnology for gene therapy and gene delivery. Written by prominent authors in the field, this book covers various aspects of gene delivery including challenges in delivering gene therapy, advances in genome editing, RNA-based gene therapy, Green nanoparticles for oligonucleotide delivery. Additional features include" Provides the most up to date information on the development of gene therapy, from the technology involved to gene correction and genome editing. Includes knowledge of the current application of CRISPR/Cas9 gene-editing technique; an approach that has recently been given the Noble Prize. Examines the development of mRNA vaccines for Covid -19 in challenging pandemic scenario Discusses siRNA, mRNA, and DNA plasmids. ¿Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Dr. Yashwant Pathak completed his Ph.D. in Pharmaceutical Technology from Nagpur University, India and his EMBA MS in Conflict Management from Sullivan University. He is Professor and Associate Dean for Faculty Affairs at the College of Pharmacy, University of South Florida. Tampa, Florida. With extensive experience in academia as well as industry, he has more than 100 publications, two patents and two patent applications, twenty edited books published, including seven books in Nanotechnology and six in Nutraceuticals and drug delivery systems. He has several books in cultural studies and conflict management. He has received several National and International awards. His recent assignment was Fulbright Senior Fellow in Indonesia for six months, where he traveled in seven countries and lectured in more than twenty universities. He was a key note speaker at the World Hindu Wisdom meeting in Bali, Indonesia, in June 2017 and co-chaired with the Governor of Bali. Dr Yashwant Pathak is also a Professor of Global Health with the College of Public Health at USF. Recently, his student completed a PhD in Global Health on homeopathy medicine and its efficacy, a survey of 1274 patients in Pune in India. Dr Pathak is also an adjunct faculty member at AirLangga University College of Public Health at Surabaya Indonesia.
Inhaltsangabe
Chapter 01 Challenges in delivering gene therapy Chapter 02 Advances in genome editing: the technology of choice for precise and efficient disease treatment, with special focus on nano delivery systems Chapter 03 Extracellular vesicles for nucleic acid delivery: progress and prospects for safe RNA-based gene therapy Chapter 04 Green nanoparticles for oligonucleotide delivery Chapter 05 Development of mRNA vaccines for Covid -19 in challenging Pandemic scenario Chapter 06 Gene therapy for cardiovascular diseases: clinical evidences Chapter 07 Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS Chapter 08 siRNA delivery for therapeutic applications using nanoparticles Chapter 09 Clinical perspectives on Gene therapy for retina and eye diseases Chapter 10 Herpesvirus microRNAs for use in gene therapy immune-evasion strategies Chapter 11 siRNA delivery for therapeutic applications using nanoparticles Chapter 12 Gene therapy and small molecule treatment for cystic fibrosis Chapter 13 CRISPR gene therapy recent trends and clinical applications Chapter 14 Clinical applications of gene therapy for Immuno-deficiencies Chapter 15 Regulatory challenges for nano gene delivery
Chapter 01 Challenges in delivering gene therapy Chapter 02 Advances in genome editing: the technology of choice for precise and efficient disease treatment, with special focus on nano delivery systems Chapter 03 Extracellular vesicles for nucleic acid delivery: progress and prospects for safe RNA-based gene therapy Chapter 04 Green nanoparticles for oligonucleotide delivery Chapter 05 Development of mRNA vaccines for Covid -19 in challenging Pandemic scenario Chapter 06 Gene therapy for cardiovascular diseases: clinical evidences Chapter 07 Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS Chapter 08 siRNA delivery for therapeutic applications using nanoparticles Chapter 09 Clinical perspectives on Gene therapy for retina and eye diseases Chapter 10 Herpesvirus microRNAs for use in gene therapy immune-evasion strategies Chapter 11 siRNA delivery for therapeutic applications using nanoparticles Chapter 12 Gene therapy and small molecule treatment for cystic fibrosis Chapter 13 CRISPR gene therapy recent trends and clinical applications Chapter 14 Clinical applications of gene therapy for Immuno-deficiencies Chapter 15 Regulatory challenges for nano gene delivery
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826